1.
Record response to call for new astronauts
WASHINGTON, Oct. 3 (UPI) -- The U.S. Food and Drug Administration tightened its potency specifications for the thyroid drug levothyroxine sodium.
The new rules for the drug, which is used to treat underactive thyroid glands and other thyroid conditions, are designed to ensure it retains its potency during its entire shelf life.
Levothyroxine sodium products are used by more than 13 million patients. The drug is manufactured under the brand names Synthroid, Levoxyl, Levothroid and Unithroid.
The FDA is mandating levothyroxine sodium drug products meet a 95 percent to 105 percent potency specification until their expiration date. The shelf life is the length of time a drug can be stored before it degrades to unacceptable levels.
FDA officials said the 95 percent lower potency specification will ensure the drugs don't degrade by more than 5 percent of the labeled claim before their expiration date and the 105 percent upper specification addresses occasional analytical testing variability.
Currently, the products are allowed a potency range of 90 percent to 110 percent.
|
|
|
| Additional Science News Stories | |
WASHINGTON, Feb. 9 (UPI) --
The late Steve Jobs, co-founder of the U.S. computer giant Apple, had faults in his personal life but was a business visionary, associates told the FBI.
|
NEW YORK, Feb. 9 (UPI) --
Macaulay Culkin is in "perfectly good health," his publicist said after the former child star was photographed looking gaunt and disheveled in New York.
|
GREENBELT, Md., Feb. 9 (UPI) --
NASA's Mars Reconnaissance Orbiter has captured the first color image from orbit of the three-petal lander of NASA's 2004 Rover Spirit mission, scientists say.
|
BREDA, Netherlands, Feb. 9 (UPI) --
A Dutch collector has said he's willing to sell his collection of rare liquors -- which he calls the world's largest -- for $8 million.
|
| Stories | Photos | People | Comments |
View Caption
